Skip to main content

West Virginia Medical Marijuana Sales Start Delayed Until 2021 Or 2022

Two steps forward, one back

It’s interesting to contrast differing banking news that hit this week in West Virginia and Florida.

West Virginia Gov. Jim Justice signed a medical marijuana banking bill that will allow financial institutions in the state to bid on providing banking services related to the state’s MMJ program.

But SunTrust Bank in Tallahassee, Florida, revealed it was closing the account of the Medical Marijuana Business Association of Florida on April 18.

MJBizDaily takeaway: Any moves to improve cannabis banking access are welcome, but short of federal action (click here for more on that topic), banks will remain leery of taking marijuana business customers, noted Rachel Gillette, head of the cannabis practice at the Greenspoon Marder law firm.

SunTrust’s move against the Florida MMJ association “highlights the urgency” of passing a federal banking bill, Gillette said.

In a blow to businesses hoping to quickly enter the West Virginia medical marijuana market, it could take up to three years before the new cannabis program is launched, a state official confirmed to Marijuana Business Daily.

Allison Adler, director of communications for the West Virginia Department of Health, wrote in an email to MJBizDaily  that the “primary cause” behind the projected two-to-three year delay is concern over the ability of MMJ companies to secure banking services. The banking issue was addressed in recent legislation.

The state treasurer, Adler noted, recently issued a request for proposals from financial institutions interested in providing banking services to the industry. However, the proposals will “require time to evaluate and implement.”

Adler continued that “it is important to note that after a solution to the current banking issue is found, it will take time for multiple stages of the medical cannabis permitting process to be implemented.”

The whole process, she added, also requires program staffing and development, rules implementation, and registration of medical providers and patients.

Advance work already undertaken by the state should shorten this timeline, according to Adler. Still, her office  estimates it will take two to three years after a fix to the banking issue before dispensaries will open.

MJBizDaily previously projected sales would start sometime in 2020.

When West Virginia’s program is up and running, it will have these business elements, according to legislation passed in May:

  • Up to 10 growers. Each grower may have up to two locations per permit.
  • Up to 10 processors.
  • Up to 100 dispensaries.

An individual or business is permitted to hold a grower, processor and dispensary permit, but one individual can’t hold more than 10 dispensary permits.

Before a permit is issued, the applicant must get written approval from the board of health in the county where the business is going to be located.

Original Article Source: https://mjbizdaily.com/west-virginia-medical-marijuana-sales-start-delayed-until-2021-or-2022/

Comments

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...